MX2016015197A - Complejo de quitina-glucano, su preparacion y usos. - Google Patents

Complejo de quitina-glucano, su preparacion y usos.

Info

Publication number
MX2016015197A
MX2016015197A MX2016015197A MX2016015197A MX2016015197A MX 2016015197 A MX2016015197 A MX 2016015197A MX 2016015197 A MX2016015197 A MX 2016015197A MX 2016015197 A MX2016015197 A MX 2016015197A MX 2016015197 A MX2016015197 A MX 2016015197A
Authority
MX
Mexico
Prior art keywords
chitin
preparation
glucan complex
biocomposite powder
glucan
Prior art date
Application number
MX2016015197A
Other languages
English (en)
Inventor
Silva Cruz Fernando Miguel Da
SILVA FARINHA Inês DA
Filomena Andrade De Freitas Maria
D'ascensão Carvalho Fernandes De Miranda Reis Maria
Original Assignee
Pharma73 S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma73 S A filed Critical Pharma73 S A
Publication of MX2016015197A publication Critical patent/MX2016015197A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Abstract

Un polvo de biocompuesto que comprende 20-95% (p/p) de complejo de quitina-glucano (CGC) y hasta 50% (p/p) de polisacáridos que contienen manosa, en el que el polvo biocompuesto tiene una densidad aparente de 0.5 a 1.0 g/cm3, y en el que más del 60% (p/p) de las partículas del polvo biocompuesto tienen un tamaño por debajo de 212 mm.
MX2016015197A 2014-05-21 2015-05-19 Complejo de quitina-glucano, su preparacion y usos. MX2016015197A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462001306P 2014-05-21 2014-05-21
PCT/IB2015/000708 WO2015177622A1 (en) 2014-05-21 2015-05-19 Chitin-glucan complex, its preparation, and uses

Publications (1)

Publication Number Publication Date
MX2016015197A true MX2016015197A (es) 2017-06-29

Family

ID=53524915

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016015197A MX2016015197A (es) 2014-05-21 2015-05-19 Complejo de quitina-glucano, su preparacion y usos.

Country Status (11)

Country Link
US (1) US11077060B2 (es)
EP (1) EP3145494A1 (es)
CN (1) CN106572959A (es)
AU (2) AU2015263025A1 (es)
BR (1) BR112016027254A8 (es)
CA (1) CA2949752A1 (es)
IL (1) IL249073B (es)
MA (1) MA40022A (es)
MX (1) MX2016015197A (es)
SG (2) SG10201810255YA (es)
WO (1) WO2015177622A1 (es)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2118370A (en) 1932-01-30 1938-05-24 Industrikemiska Ab Method of treating fermenting liquids
US4992540A (en) 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
GB2259709A (en) 1991-09-19 1993-03-24 British Textile Tech Production of chitin/chitosan
US5169638A (en) 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
US5654007A (en) 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
US6210686B1 (en) 1998-12-18 2001-04-03 Beth Israel Deaconess Medical Center Dietary supplement and method for lowering risk of heart disease
US20070299034A1 (en) * 2002-02-12 2007-12-27 Marie-France Versali Cell wall derivatives, their preparation process, and use thereof
BE1014638A6 (fr) 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
WO2004092391A2 (en) 2003-04-11 2004-10-28 Arkion Life Sciences Llc Metabolic engineering for enhanced production of chitin and chitosan in microorganisms
US7608270B2 (en) * 2003-06-27 2009-10-27 University Of Hull Dosage form
WO2006121803A1 (en) 2005-05-05 2006-11-16 Sensient Flavors Inc. Production of beta-glucans and mannans
FR2908771B1 (fr) * 2006-11-20 2011-07-29 Kitozyme Sa Chitine-glucane d'extrait fongique de granulometrie fine
PT103714B (pt) 2007-04-11 2020-07-28 73100 - Setenta E Três Mil E Cem, Lda. Processo para a obtenção de um polímero à base de galactose
PT104149B (pt) * 2008-07-30 2020-05-08 73100 - Setenta E Três Mil E Cem, Lda. Processo de co-produção de quitina, seus derivados e polímeros contendo glucose, manose e/ou galactose, por cultivo da levedura pichia pastoris
EP2221358A1 (en) 2009-02-24 2010-08-25 Universität für Bodenkultur Wien Biotin-prototrophic yeasts
US8748123B2 (en) 2009-12-15 2014-06-10 73100-Setenta e Tres Mil e Cem, Lda. Fucose-containing bacterial biopolymer
WO2013140222A1 (en) * 2012-03-23 2013-09-26 Pharma73, S.A. Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient

Also Published As

Publication number Publication date
US20170079917A1 (en) 2017-03-23
EP3145494A1 (en) 2017-03-29
SG11201609605RA (en) 2016-12-29
SG10201810255YA (en) 2018-12-28
BR112016027254A8 (pt) 2021-06-29
IL249073A0 (en) 2017-01-31
IL249073B (en) 2021-04-29
CA2949752A1 (en) 2015-11-26
WO2015177622A1 (en) 2015-11-26
BR112016027254A2 (pt) 2017-08-15
MA40022A (fr) 2015-11-26
AU2015263025A1 (en) 2017-01-12
AU2020210208A1 (en) 2020-08-20
US11077060B2 (en) 2021-08-03
CN106572959A (zh) 2017-04-19

Similar Documents

Publication Publication Date Title
MX2021003256A (es) Articulo abrasivo que incluye particulas abrasivas perfiladas.
CN106687083A8 (zh) 吸收制品
AU366476S (en) Bottle
MX2016013376A (es) Polvo de sinterizacion de baja presion.
EP3083938A4 (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
MY169154A (en) Tobacco material, tobacco product to which tobacco material is added, and method for producing tobacco material
AU2016202480A1 (en) Seed-origin endophyte populations, compositions, and methods of use
MX2017015414A (es) Salmuera de alta densidad que contiene particulas coloidales.
PH12015500217B1 (en) A capsule for use in a food preparation machine
EP3191499A4 (en) Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
MX2016003711A (es) Particulas.
MX2015015923A (es) Encapsulados.
MA39883A (fr) Particules inorganiques individualisées
EP3033401A4 (en) Submicron silver particle ink compositions, process and applications
AU356379S (en) Bottle
MX2015013014A (es) Granulos de harina de microalgas y proceso de preparacion de estos.
EP3202833A4 (en) Expanded article, and expanded particles used to produce same
GB2540825A (en) Improved suspension of proppant particles in hydraulic fracturing fluid
WO2015058664A8 (zh) 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途
MX2016006916A (es) Composicion farmaceutica, que comprende particulas de aglutinante de fosfato.
GB201210060D0 (en) Composition
MX2016016613A (es) Composicion en forma de particulas compactadas y su uso.
PH12015501442A1 (en) Non-replicating virus-derived particles and uses thereof
MX2015014382A (es) Composicion de resina y articulo moldeado.